TAKEPRON Side Effects

6831727-X | Liver Disorder, Pneumonia Aspiration
on Jul 02, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with schizophrenia and was treated with Takepron (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, pneumonia aspiration. Takepron dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), SOLDACTONE (View Soldactone Review and Soldactone Label ), MAGLAX (View Maglax Review and Maglax Label ), ZYPREXA (2.5mg In Morning And 5mg Before Sleep) (View Zyprexa Review and Zyprexa Label ), SILECE (View Silece Review and Silece Label ), GLYCYRRHIZIC ACID (Dose:1 Unit(s)) (View Glycyrrhizic Acid Review and Glycyrrhizic Acid Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6779528-5 | Hepatic Function Abnormal, Pneumonia Aspiration
Patient was taking Takepron (View Usage). Patient had the following side effects: hepatic function abnormal, pneumonia aspiration on May 20, 2010 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with schizophrenia and. Takepron dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), SOLDACTONE (View Soldactone Review and Soldactone Label ), MAGLAX (View Maglax Review and Maglax Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), SILECE (View Silece Review and Silece Label ), GLYCYRRHIZIC ACID (Dose:1 Unit(s)) (View Glycyrrhizic Acid Review and Glycyrrhizic Acid Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6394095-6 | Pleurisy
Adverse event was reported on Sep 28, 2009 by a Female patient taking Takepron (View Usage) (Dosage: ) . Location: JAPAN , 78 years of age, After Takepron was administered, patient had the following side effects: pleurisy. During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

6265378-5 | Enterocolitis Haemorrhagic
on Jul 07, 2009 Male patient from JAPAN , 67 years of age, was diagnosed with helicobacter infection and was treated with Takepron (View Usage). Patient experienced the following unwanted or unexpected effects: enterocolitis haemorrhagic. Takepron dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.


6247771-X | Hepatitis Cholestatic, Jaundice Cholestatic
on Jun 19, 2009 Male patient from JAPAN , weighting 147.7 lb, was diagnosed with gastric ulcer, angina pectoris, cardiac failure, tinea infection (What is tinea infection?), percutaneous coronary intervention and was treated with Takepron (View Usage). Patient had the following side effects: hepatitis cholestatic, jaundice cholestatic. Takepron dosage: . During the same period patient was treated with SIGMART (View Sigmart Review and Sigmart Label ), SERALA (View Serala Review and Serala Label ), LAMISIL (View Lamisil Review and Lamisil Label ), LASIX (View Lasix Review and Lasix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (300 Mg Once Followed By 75 Mg Daily) (View Plavix Review and Plavix Label ).

6192492-5 | Colitis Collagenous, Haemoglobin Decreased, Large Intestinal Ulcer, Ulcer Haemorrhage
Patient was taking Takepron (View Usage). After Takepron was administered, patient had the following side effects: colitis collagenous, haemoglobin decreased, large intestinal ulcer, ulcer haemorrhage on May 07, 2009 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with gastric ulcer and. Takepron dosage: 15 Mg (15 Mg,1 In 1 D) Per Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), FOIPAN (CAMOSTAT MESILATE) (View Foipan (camostat Mesilate) Review and Foipan (camostat Mesilate) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6145284-7 | Acute Prerenal Failure, Blood Creatinine Increased, Dehydration, Hypereosinophilic Syndrome, Rash Scarlatiniform
Adverse event was reported on Mar 30, 2009 by a Male patient taking Takepron (View Usage) (Dosage: ) was diagnosed with gastric ulcer, oedema peripheral, cough, constipation (What is constipation?), pain in extremity, insomnia and. Location: JAPAN , weighting 145.1 lb, Patient experienced the following unwanted or unexpected effects: acute prerenal failure, blood creatinine increased, dehydration, hypereosinophilic syndrome, rash scarlatiniform. During the same period patient was treated with DIART (1 Unit) (View Diart Review and Diart Label ), HUSCODE (View Huscode Review and Huscode Label ), FLOMOX (View Flomox Review and Flomox Label ), COUGHNOL (View Coughnol Review and Coughnol Label ), MAGMITT (View Magmitt Review and Magmitt Label ), TERNELIN (View Ternelin Review and Ternelin Label ), DORAL (View Doral Review and Doral Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

6094436-3 | Hypereosinophilic Syndrome, Oedema Peripheral, Rash
on Feb 19, 2009 Male patient from JAPAN , 78 years of age, was diagnosed with prophylaxis, cerebral infarction and was treated with Takepron (View Usage). Patient had the following side effects: hypereosinophilic syndrome, oedema peripheral, rash (What is rash?). Takepron dosage: Unk. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6080832-7 | Hypereosinophilic Syndrome, Oedema Peripheral, Rash
on Feb 10, 2009 Male patient from JAPAN , 78 years of age, was diagnosed with prophylaxis, cerebral infarction and was treated with Takepron (View Usage). After Takepron was administered, patient had the following side effects: hypereosinophilic syndrome, oedema peripheral, rash (What is rash?). Takepron dosage: Unk. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6075978-3 | Cholestasis, Jaundice Cholestatic
Patient was taking Takepron (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, jaundice cholestatic on Feb 04, 2009 from JAPAN Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with stent placement, acute myocardial infarction and. Takepron dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (300 Mg Once Followed By 75 Mg Daily) (View Plavix Review and Plavix Label ). Patient was hospitalized and became disabled.

5814645-5 | Ectopic Pregnancy
Adverse event was reported on Jul 08, 2008 by a Female patient taking Takepron (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease and. Location: JAPAN , 41 years of age, Patient had the following side effects: ectopic pregnancy. Patient was hospitalized.

5701595-8 | C-reactive Protein Increased, Pyrexia
on Apr 01, 2008 Male patient from JAPAN , weighting 160.9 lb, was diagnosed with prophylaxis against gastrointestinal ulcer, brain stem infarction and was treated with Takepron (View Usage). After Takepron was administered, patient had the following side effects: c-reactive protein increased, pyrexia. Takepron dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

5620185-9 | Embolic Cerebral Infarction
on Jan 29, 2008 Female patient from JAPAN , weighting 112.4 lb, was diagnosed with lacunar infarction, hyperlipidaemia and was treated with Takepron (View Usage). Patient experienced the following unwanted or unexpected effects: embolic cerebral infarction. Takepron dosage: 15 Mg. During the same period patient was treated with ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ULCERLMIN (3 G) (View Ulcerlmin Review and Ulcerlmin Label ), LIVALO (1 Mg) (View Livalo Review and Livalo Label ). Patient was hospitalized.

5581654-3 | Colitis Ischaemic
Patient was taking Takepron (View Usage). Patient had the following side effects: colitis ischaemic on Dec 28, 2007 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with gastric ulcer and. Takepron dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

5577865-3 | Coma
Adverse event was reported on Dec 20, 2007 by a Female patient taking Takepron (View Usage) (Dosage: 15 Mg) was diagnosed with acute myocardial infarction, postoperative analgesia, insomnia and. Location: JAPAN , weighting 82.45 lb, After Takepron was administered, patient had the following side effects: coma. During the same period patient was treated with PANALDINE (200 Mg) (View Panaldine Review and Panaldine Label ), LIPITOR (10 Mg) (View Lipitor Review and Lipitor Label ), ASPIRIN (100 Mg) (View Aspirin Review and Aspirin Label ), LOBU (View Lobu Review and Lobu Label ), MYSLEE (View Myslee Review and Myslee Label ), DIOVAN (40 Mg) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5566480-3 | Colitis Ischaemic
on Dec 12, 2007 Female patient from JAPAN , 58 years of age, was diagnosed with gastric ulcer and was treated with Takepron (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic. Takepron dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), AMOXICILLIN TRIHYDRATE (View Amoxicillin Trihydrate Review and Amoxicillin Trihydrate Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

5213217-3 | Oculomucocutaneous Syndrome
on Sep 12, 2006 Male patient from JAPAN , 70 years of age, was diagnosed with reflux oesophagitis and was treated with Takepron (View Usage). Patient had the following side effects: oculomucocutaneous syndrome. Takepron dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LOXONIN /00890701/ (View Loxonin /00890701/ Review and Loxonin /00890701/ Label ). Patient was hospitalized.

5023744-X | Cardiac Failure, Pulmonary Alveolar Haemorrhage
Patient was taking Takepron (View Usage). After Takepron was administered, patient had the following side effects: cardiac failure, pulmonary alveolar haemorrhage on May 26, 2006 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with reflux oesophagitis and. Takepron dosage: 15 Mg (15 Mg, 1 In 1 D). During the same period patient was treated with BUFFERIN (View Bufferin Review and Bufferin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ), MEXITIL (View Mexitil Review and Mexitil Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ).